-
1
-
-
0024160877
-
Banting lecture Role of insulin resistance in human disease
-
Reaven, G. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 1988, 37, 1595-607.
-
(1988)
Diabetes
, vol.1988
, Issue.37
, pp. 1595-1607
-
-
Reaven, G.1
-
2
-
-
0034837376
-
Cardiovascular morbidity and mortality associated with the metabolic syndrome
-
Isomaa, B.; Almgren, P.; Tuomi, T.; Forsén, B.; Lahti, K.; Nissén, M.; Taskinen, M.; Groop, L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24, 683-9.
-
(2001)
Diabetes Care
, vol.24
, pp. 683-689
-
-
Isomaa, B.1
Almgren, P.2
Tuomi, T.3
Forsén, B.4
Lahti, K.5
Nissén, M.6
Taskinen, M.7
Groop, L.8
-
3
-
-
0042665536
-
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study
-
Sattar, N.; Gaw, A.; Scherbakova, O.; Ford, I.; O'Reilly, D.; Haffner, S.; Isles, C.; Macfarlane, P.; Packard, C.; Cobbe, S.; Shepherd, J. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 2003, 108, 414-9.
-
(2003)
Circulation
, vol.108
, pp. 414-419
-
-
Sattar, N.1
Gaw, A.2
Scherbakova, O.3
Ford, I.4
O'Reilly, D.5
Haffner, S.6
Isles, C.7
Macfarlane, P.8
Packard, C.9
Cobbe, S.10
Shepherd, J.11
-
4
-
-
4444329030
-
National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study
-
Hunt, K.; Resendez, R.; Williams, K.; Haffner, S.; Stern, M. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation, 2004, 110, 1251-7.
-
(2004)
Circulation
, vol.110
, pp. 1251-1257
-
-
Hunt, K.1
Resendez, R.2
Williams, K.3
Haffner, S.4
Stern, M.5
-
5
-
-
38549112963
-
High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review
-
Amarenco, P.; Labreuche, J.; Touboul, P. High-density lipoproteincholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis, 2008, 196, 489-96.
-
(2008)
Atherosclerosis
, vol.196
, pp. 489-496
-
-
Amarenco, P.1
Labreuche, J.2
Touboul, P.3
-
6
-
-
0024996141
-
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis
-
Tall, A. J. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. Clin. Invest., 1990, 86, 379-84.
-
(1990)
Clin. Invest
, vol.86
, pp. 379-384
-
-
Tall, A.J.1
-
7
-
-
33747806291
-
Després, Metabolic syndrome: The danger signal in atherosclerosis
-
Mathieu, P.; Pibarot, P.; Després, Metabolic syndrome: the danger signal in atherosclerosis. J. Vasc. Health Risk Manag., 2006, 2, 285-302.
-
(2006)
J. Vasc. Health Risk Manag
, vol.2
, pp. 285-302
-
-
Mathieu, P.1
Pibarot, P.2
-
8
-
-
33744948336
-
Metabolic syndrome, inflammation and atherosclerosis
-
Paoletti, R.; Bolego, C.; Poli, A.; Cignarella, A. Metabolic syndrome, inflammation and atherosclerosis. Vasc. Health Risk Manag., 2006, 2, 145-52.
-
(2006)
Vasc. Health Risk Manag
, vol.2
, pp. 145-152
-
-
Paoletti, R.1
Bolego, C.2
Poli, A.3
Cignarella, A.4
-
9
-
-
2542455861
-
Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): Variation in LIPC gene associates with clinical outcomes in patients with established CAD
-
Baroni, M.; Berni, A.; Romeo, S.; Arca, M.; Tesorio, T.; Sorropago, G.; Di Mario, U.; Galton, D. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD. BMC Med. Genet., 2003, 4, 8.
-
(2003)
BMC Med. Genet
, vol.4
, pp. 8
-
-
Baroni, M.1
Berni, A.2
Romeo, S.3
Arca, M.4
Tesorio, T.5
Sorropago, G.6
Di Mario, U.7
Galton, D.8
-
10
-
-
58249090844
-
Differential influence of different dietary fatty acids on very low-density lipoprotein secretion when delivered to hepatocytes in chylomicron remnants
-
López-Soldado, I.; Avella, M.; Botham, K. Differential influence of different dietary fatty acids on very low-density lipoprotein secretion when delivered to hepatocytes in chylomicron remnants. Metabolism, 2009, 58, 186-95.
-
(2009)
Metabolism
, vol.58
, pp. 186-195
-
-
López-Soldado, I.1
Avella, M.2
Botham, K.3
-
11
-
-
0037900979
-
Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors
-
Lee, C.; Olson, P.; Evans, R. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology, 2003, 144, 2201-7.
-
(2003)
Endocrinology
, vol.144
, pp. 2201-2207
-
-
Lee, C.1
Olson, P.2
Evans, R.3
-
12
-
-
54249156545
-
Metabolic Syndrome: From Epidemiology to Systems Biology
-
Lusis, A.; Attie, A.; Reue, K. Metabolic syndrome: from epidemiology to systems biology. Nat. Rev. Genet., 2008, 9, 819-30.
-
Nat. Rev. Genet.
, vol.9
, pp. 819-830
-
-
Lusis, A.1
Attie, A.2
Reue, K.3
-
13
-
-
0030949093
-
Genes and the development of vascular disease
-
Foy, C.; Grant, P. Genes and the development of vascular disease. Postgrad. Med. J., 1997, 73, 271-8.
-
(1997)
Postgrad. Med. J
, vol.73
, pp. 271-278
-
-
Foy, C.1
Grant, P.2
-
14
-
-
58749086556
-
Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies
-
Colombo, M.; Botto, N.; Vittorini, S.; Paradossi, U.; Andreassi, M. Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies. Cardiovasc. Ultrasound, 2008, 6, 62.
-
(2008)
Cardiovasc. Ultrasound
, vol.6
, pp. 62
-
-
Colombo, M.1
Botto, N.2
Vittorini, S.3
Paradossi, U.4
Andreassi, M.5
-
15
-
-
77953412320
-
Genetics of coronary artery disease: Focus on genomewide association studies
-
Baudhuin, L. Genetics of coronary artery disease: focus on genomewide association studies. Am. J. Transl. Res., 2009, 1, 221-34.
-
(2009)
Am. J. Transl. Res
, vol.1
, pp. 221-234
-
-
Baudhuin, L.1
-
16
-
-
33644840046
-
Genetic susceptibility to coronary artery disease: From promise to progress
-
Watkins, H.; Farrall, M. Genetic susceptibility to coronary artery disease: from promise to progress. Nat. Rev. Genet., 2006, 7, 163-73.
-
(2006)
Nat. Rev. Genet
, vol.7
, pp. 163-173
-
-
Watkins, H.1
Farrall, M.2
-
17
-
-
0029838433
-
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
-
Hokanson, J.; Austin, M. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk, 1996, 3, 213-9.
-
(1996)
J. Cardiovasc. Risk
, vol.3
, pp. 213-219
-
-
Hokanson, J.1
Austin, M.2
-
18
-
-
0035756399
-
A risk factor for atherosclerosis: Triglyceriderich lipoproteins
-
Malloy, M.; Kane, J. A risk factor for atherosclerosis: triglyceriderich lipoproteins. Adv. Intern. Med., 2001, 47, 111-36.
-
(2001)
Adv. Intern. Med
, vol.47
, pp. 111-136
-
-
Malloy, M.1
Kane, J.2
-
19
-
-
15944403233
-
Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease
-
Hopkins, P.; Wu, L.; Hunt, S.; Brinton, E. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J. Am. Coll. Cardiol., 2005, 45, 1003-12.
-
(2005)
J. Am. Coll. Cardiol
, vol.45
, pp. 1003-1012
-
-
Hopkins, P.1
Wu, L.2
Hunt, S.3
Brinton, E.4
-
20
-
-
0034701934
-
Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: A genome-wide scan in the Framingham study
-
Shearman, A.; Ordovas, J.; Cupples, L.; Schaefer, E.; Harmon, M.; Shao, Y.; Keen, J.; DeStefano, A.; Joost, O.; Wilson, P.; Housman, D.; Myers, R. Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum. Mol. Genet., 2000, 9, 1315-20.
-
(2000)
Hum. Mol. Genet
, vol.9
, pp. 1315-1320
-
-
Shearman, A.1
Ordovas, J.2
Cupples, L.3
Schaefer, E.4
Harmon, M.5
Shao, Y.6
Keen, J.7
Destefano, A.8
Joost, O.9
Wilson, P.10
Housman, D.11
Myers, R.12
-
21
-
-
33947146635
-
The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: An angiographic study
-
Martinelli, N.; Trabetti, E.; Bassi, A.; Girelli, D.; Friso, S.; Pizzolo, F.; Sandri, M.; Malerba, G.; Pignatti, P.; Corrocher, R.; Olivieri, O. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis, 2007, 191, 409-17.
-
(2007)
Atherosclerosis
, vol.191
, pp. 409-417
-
-
Martinelli, N.1
Trabetti, E.2
Bassi, A.3
Girelli, D.4
Friso, S.5
Pizzolo, F.6
Sandri, M.7
Malerba, G.8
Pignatti, P.9
Corrocher, R.10
Olivieri, O.11
-
22
-
-
34848871920
-
A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency
-
Okubo, M.; Horinishi, A.; Saito, M.; Ebara, T.; Endo, Y.; Kaku, K.; Murase, T.; Eto, M. A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency. Mol. Genet. Metab., 2007, 92, 229-33
-
(2007)
Mol. Genet. Metab
, vol.92
, pp. 229-233
-
-
Okubo, M.1
Horinishi, A.2
Saito, M.3
Ebara, T.4
Endo, Y.5
Kaku, K.6
Murase, T.7
Eto, M.A.8
-
23
-
-
35148835708
-
Genetics of cardiovascular diseases: From single mutations to the whole genome
-
Cambien, F.; Tiret, L. Genetics of cardiovascular diseases: from single mutations to the whole genome. Circulation, 2007, 116, 1714-24.
-
(2007)
Circulation
, vol.116
, pp. 1714-1724
-
-
Cambien, F.1
Tiret, L.2
-
24
-
-
34249888775
-
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
-
Saxena, R.; Voight, B.; Lyssenko, V.; Burtt, N.; de Bakker, P.; Chen, H.; Roix, J.; Kathiresan, S.; Hirschhorn, J.; Daly, M.; Hughes, T.; Groop, L.; Altshuler, D.; Almgren, P.; Florez, J.; Meyer, J.; Ardlie, K.; Bengtsson Boström, K.; Isomaa, B.; Lettre, G.; Lindblad, U.; Lyon, H.; Melander, O.; Newton-Cheh, C.; Nilsson, P.; Orho-Melander, M.; Råstam, L.; Speliotes, E.; Taskinen, M.; Tuomi, T.; Guiducci, C.; Berglund, A.; Carlson, J.; Gianniny, L.; Hackett, R.; Hall, L.; Holmkvist, J.; Laurila, E.; Sjögren, M.; Sterner, M.; Surti, A.; Svensson, M.; Tewhey, R.; Blumenstiel, B.; Parkin, M.; Defelice, M.; Barry, R.; Brodeur, W.; Camarata, J.; Chia, N.; Fava, M.; Gibbons, J.; Handsaker, B.; Healy, C.; Nguyen, K.; Gates, C.; Sougnez, C.; Gage, D.; Nizzari, M.; Gabriel, S.; Chirn, G.; Ma, Q.; Parikh, H.; Richardson, D.; Ricke, D.; Purcell, S. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science, 2007, 316, 1331-6.
-
(2007)
Science
, vol.316
, pp. 1331-1336
-
-
Saxena, R.1
Voight, B.2
Lyssenko, V.3
Burtt, N.4
de Bakker, P.5
Chen, H.6
Roix, J.7
Kathiresan, S.8
Hirschhorn, J.9
Daly, M.10
Hughes, T.11
Groop, L.12
Altshuler, D.13
Almgren, P.14
Florez, J.15
Meyer, J.16
Ardlie, K.17
Bengtsson Boström, K.18
Isomaa, B.19
Lettre, G.20
Lindblad, U.21
Lyon, H.22
Melander, O.23
Newton-Cheh, C.24
Nilsson, P.25
Orho-Melander, M.26
Råstam, L.27
Speliotes, E.28
Taskinen, M.29
Tuomi, T.30
Guiducci, C.31
Berglund, A.32
Carlson, J.33
Gianniny, L.34
Hackett, R.35
Hall, L.36
Holmkvist, J.37
Laurila, E.38
Sjögren, M.39
Sterner, M.40
Surti, A.41
Svensson, M.42
Tewhey, R.43
Blumenstiel, B.44
Parkin, M.45
Defelice, M.46
Barry, R.47
Brodeur, W.48
Camarata, J.49
Chia, N.50
Fava, M.51
Gibbons, J.52
Handsaker, B.53
Healy, C.54
Nguyen, K.55
Gates, C.56
Sougnez, C.57
Gage, D.58
Nizzari, M.59
Gabriel, S.60
Chirn, G.61
Ma, Q.62
Parikh, H.63
Richardson, D.64
Ricke, D.65
Purcell, S.66
more..
-
25
-
-
0026514988
-
Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis
-
Dallongeville, J.; Lussier-Cacan, S.; Davignon, J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J. Lipid Res., 1992, 33, 447-54.
-
(1992)
J. Lipid Res
, vol.33
, pp. 447-454
-
-
Dallongeville, J.1
Lussier-Cacan, S.2
Davignon, J.3
-
26
-
-
28444457032
-
Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men
-
Dallongeville, J.; Cottel, D.; Montaye, M.; Codron, V.; Amouyel, P.; Helbecque, N. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int. J. Cardiol., 2006, 106, 152-6.
-
(2006)
Int. J. Cardiol
, vol.106
, pp. 152-156
-
-
Dallongeville, J.1
Cottel, D.2
Montaye, M.3
Codron, V.4
Amouyel, P.5
Helbecque, N.6
-
27
-
-
58149161560
-
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
-
Aulchenko, Y.; Ripatti, S.; Lindqvist, I.; Boomsma, D.; Heid, I.; Pramstaller, P.; Penninx, B.; Janssens, A.; Wilson, J.; Spector, T.; Martin, N.; Pedersen, N.; Kyvik, K.; Kaprio, J.; Hofman, A.; Freimer, N.; Jarvelin, M.; Gyllensten, U.; Campbell, H.; Rudan, I.; Johansson, A.; Marroni, F.; Hayward, C.; Vitart, V.; Jonasson, I.; Pattaro, C.; Wright, A.; Hastie, N.; Pichler, I.; Hicks, A.; Falchi, M.; Willemsen, G.; Hottenga, J.; de Geus, E.; Montgomery, G.; Whitfield, J.;Magnusson, P.; Saharinen, J.; Perola, M.; Silander, K.; Isaacs, A.; Sijbrands, E.; Uitterlinden, A.; Witteman, J.; Oostra, B.; Elliott, P.; Ruokonen, A.; Sabatti, C.; Gieger, C.; Meitinger, T.; Kronenberg, F.; Döring, A.; Wichmann, H.; Smit, J.; McCarthy, M.; van Duijn, C.; Peltonen, L. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet., 2009, 41, 47-55.
-
(2009)
Nat. Genet.
, vol.41
, pp. 47-55
-
-
Aulchenko, Y.1
Ripatti, S.2
Lindqvist, I.3
Boomsma, D.4
Heid, I.5
Pramstaller, P.6
Penninx, B.7
Janssens, A.8
Wilson, J.9
Spector, T.10
Martin, N.11
Pedersen, N.12
Kyvik, K.13
Kaprio, J.14
Hofman, A.15
Freimer, N.16
Jarvelin, M.17
Gyllensten, U.18
Campbell, H.19
Rudan, I.20
Johansson, A.21
Marroni, F.22
Hayward, C.23
Vitart, V.24
Jonasson, I.25
Pattaro, C.26
Wright, A.27
Hastie, N.28
Pichler, I.29
Hicks, A.30
Falchi, M.31
Willemsen, G.32
Hottenga, J.33
de Geus, E.34
Montgomery, G.35
Whitfield, J.36
Magnusson, P.37
Saharinen, J.38
Perola, M.39
Silander, K.40
Isaacs, A.41
Sijbrands, E.42
Uitterlinden, A.43
Witteman, J.44
Oostra, B.45
Elliott, P.46
Ruokonen, A.47
Sabatti, C.48
Gieger, C.49
Meitinger, T.50
Kronenberg, F.51
Döring, A.52
Wichmann, H.53
Smit, J.54
McCarthy, M.55
van Duijn, C.56
Peltonen, L.57
more..
-
28
-
-
58149163149
-
Common variants at 30 loci contribute to polygenic dyslipidemia. Nat
-
Kathiresan, S.; Willer, C.; Peloso, G.; Demissie, S.; Musunuru, K.; Schadt, E.; Kaplan, L.; Bennett, D.; Li, Y.; Tanaka, T.; Voight, B.; Bonnycastle, L.; Jackson, A.; Crawford, G.; Surti, A.; Guiducci, C.; Burtt, N.; Parish, S.; Clarke, R.; Zelenika, D.; Kubalanza, K.; Morken, M.; Scott, L.; Stringham, H.; Galan, P.; Swift, A.; Kuusisto, J.; Bergman, R.; Sundvall, J.; Laakso, M.; Ferrucci, L.; Scheet, P.; Sanna, S.; Uda, M.; Yang, Q.; Lunetta, K.; Dupuis, J.; de Bakker, P.; O'Donnell, C.; Chambers, J.; Kooner, J.; Hercberg, S.; Meneton, P.; Lakatta, E.; Scuteri, A.; Schlessinger, D.; Tuomilehto, J.; Collins, F.; Groop, L.; Altshuler, D.; Collins, R.; Lathrop, G.; Melander, O.; Salomaa, V.; Peltonen, L.; OrhoMelander, M.; Ordovas, J.; Boehnke, M.; Abecasis, G.; Mohlke, K.; Cupples, L. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet., 2009, 41, 56-65.
-
(2009)
Genet
, vol.41
, pp. 56-65
-
-
Kathiresan, S.1
Willer, C.2
Peloso, G.3
Demissie, S.4
Musunuru, K.5
Schadt, E.6
Kaplan, L.7
Bennett, D.8
Li, Y.9
Tanaka, T.10
Voight, B.11
Bonnycastle, L.12
Jackson, A.13
Crawford, G.14
Surti, A.15
Guiducci, C.16
Burtt, N.17
Parish, S.18
Clarke, R.19
Zelenika, D.20
Kubalanza, K.21
Morken, M.22
Scott, L.23
Stringham, H.24
Galan, P.25
Swift, A.26
Kuusisto, J.27
Bergman, R.28
Sundvall, J.29
Laakso, M.30
Ferrucci, L.31
Scheet, P.32
Sanna, S.33
Uda, M.34
Yang, Q.35
Lunetta, K.36
Dupuis, J.37
de Bakker, P.38
O'Donnell, C.39
Chambers, J.40
Kooner, J.41
Hercberg, S.42
Meneton, P.43
Lakatta, E.44
Scuteri, A.45
Schlessinger, D.46
Tuomilehto, J.47
Collins, F.48
Groop, L.49
Altshuler, D.50
Collins, R.51
Lathrop, G.52
Melander, O.53
Salomaa, V.54
Peltonen, L.55
Orhomelander, M.56
Ordovas, J.57
Boehnke, M.58
Abecasis, G.59
Mohlke, K.60
Cupples, L.61
more..
-
29
-
-
38649132270
-
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
-
Kathiresan, S.; Melander, O.; Guiducci, C.; Surti, A.; Burtt, N.; Rieder, M.; Cooper, G.; Roos, C.; Voight, B.; Havulinna, A.; Wahlstrand, B.; Hedner, T.; Corella, D.; Tai, E.; Ordovas, J.; Berglund, G.; Vartiainen, E.; Jousilahti, P.; Hedblad, B.; Taskinen, M.; Newton-Cheh, C.; Salomaa, V.; Peltonen, L.; Groop, L.; Altshuler, D.; Orho-Melander, M. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet., 2008, 40, 189-197.
-
(2008)
Nat. Genet
, vol.40
, pp. 189-197
-
-
Kathiresan, S.1
Melander, O.2
Guiducci, C.3
Surti, A.4
Burtt, N.5
Rieder, M.6
Cooper, G.7
Roos, C.8
Voight, B.9
Havulinna, A.10
Wahlstrand, B.11
Hedner, T.12
Corella, D.13
Tai, E.14
Ordovas, J.15
Berglund, G.16
Vartiainen, E.17
Jousilahti, P.18
Hedblad, B.19
Taskinen, M.20
Newton-Cheh, C.21
Salomaa, V.22
Peltonen, L.23
Groop, L.24
Altshuler, D.25
Orho-Melander, M.26
more..
-
30
-
-
38649084407
-
Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides
-
Kooner, J.; Chambers, J.; Aguilar-Salinas, C.; Hinds, D.; Hyde, C.; Warnes, G.; Gómez Pérez, F.; Frazer, K.; Elliott, P.; Scott, J.; Milos, P.; Cox, D.; Thompson, J. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat. Genet., 2008, 40, 149-51.
-
(2008)
Nat. Genet
, vol.40
, pp. 149-151
-
-
Kooner, J.1
Chambers, J.2
Aguilar-Salinas, C.3
Hinds, D.4
Hyde, C.5
Warnes, G.6
Gómez pérez, F.7
Frazer, K.8
Elliott, P.9
Scott, J.10
Milos, P.11
Cox, D.12
Thompson, J.13
-
31
-
-
38649125868
-
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
-
Willer, C.; Sanna, S.; Jackson, A.; Scuteri, A.; Bonnycastle, L.; Clarke, R.; Heath, S.; Timpson, N.; Najjar, S.; Stringham, H.; Strait, J.; Duren, W.; Maschio, A.; Busonero, F.; Mulas, A.; Albai, G.; Swift, A.; Morken, M.; Narisu, N.; Bennett, D.; Parish, S.; Shen, H.; Galan, P.; Meneton, P.; Hercberg, S.; Zelenika, D.; Chen, W.; Li, Y.; Scott, L.; Scheet, P.; Sundvall, J.; Watanabe, R.; Nagaraja, R.; Ebrahim, S.; Lawlor, D.; Ben-Shlomo, Y.; DaveySmith, G.; Shuldiner, A.; Collins, R.; Bergman, R.; Uda, M.; Tuomilehto, J.; Cao, A.; Collins, F.; Lakatta, E.; Lathrop, G.; Boehnke, M.; Schlessinger, D.; Mohlke, K.; Abecasis, G. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet., 2008, 40, 161-9.
-
(2008)
Nat. Genet
, vol.40
, pp. 161-169
-
-
Willer, C.1
Sanna, S.2
Jackson, A.3
Scuteri, A.4
Bonnycastle, L.5
Clarke, R.6
Heath, S.7
Timpson, N.8
Najjar, S.9
Stringham, H.10
Strait, J.11
Duren, W.12
Maschio, A.13
Busonero, F.14
Mulas, A.15
Albai, G.16
Swift, A.17
Morken, M.18
Narisu, N.19
Bennett, D.20
Parish, S.21
Shen, H.22
Galan, P.23
Meneton, P.24
Hercberg, S.25
Zelenika, D.26
Chen, W.27
Li, Y.28
Scott, L.29
Scheet, P.30
Sundvall, J.31
Watanabe, R.32
Nagaraja, R.33
Ebrahim, S.34
Lawlor, D.35
Ben-Shlomo, Y.36
Daveysmith, G.37
Shuldiner, A.38
Collins, R.39
Bergman, R.40
Uda, M.41
Tuomilehto, J.42
Cao, A.43
Collins, F.44
Lakatta, E.45
Lathrop, G.46
Boehnke, M.47
Schlessinger, D.48
Mohlke, K.49
Abecasis, G.50
more..
-
32
-
-
9144257873
-
Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia
-
Eichenbaum-Voline, S.; Olivier, M.; Jones, E.; Naoumova, R.; Jones, B.; Gau, B.; Patel, H.; Seed, M.; Betteridge, D.; Galton, D.; Rubin, E.; Scott, J.; Shoulders, C.; Pennacchio, L. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 167-74.
-
(2004)
Arterioscler. Thromb. Vasc. Biol
, vol.24
, pp. 167-174
-
-
Eichenbaum-Voline, S.1
Olivier, M.2
Jones, E.3
Naoumova, R.4
Jones, B.5
Gau, B.6
Patel, H.7
Seed, M.8
Betteridge, D.9
Galton, D.10
Rubin, E.11
Scott, J.12
Shoulders, C.13
Pennacchio, L.14
-
33
-
-
52949105366
-
Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease
-
Shanker, J.; Perumal, G.; Rao, V.; Khadrinarasimhiah, N.; John, S.; Hebbagodi, S.; Mukherjee, M.; Kakkar, V. Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis., 2008, 7, 33.
-
(2008)
Lipids Health Dis
, vol.7
, pp. 33
-
-
Shanker, J.1
Perumal, G.2
Rao, V.3
Khadrinarasimhiah, N.4
John, S.5
Hebbagodi, S.6
Mukherjee, M.7
Kakkar, V.8
-
34
-
-
39849087312
-
Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians
-
Kisfali, P.; Mohás, M.; Maasz, A.; Hadarits, F.; Markó, L.; Horvatovich, K.; Oroszlán, T.; Bagosi, Z.; Bujtor, Z.; Gasztonyi, B.; Wittmann, I.; Melegh, B. Apolipoprotein A5 IVS3+476A allelic variant associates with increased trigliceride levels and confers risk for development of metabolic syndrome in Hungarians. Circ. J., 2008, 72, 40-3.
-
(2008)
Circ. J
, vol.72
, pp. 40-43
-
-
Kisfali, P.1
Mohás, M.2
Maasz, A.3
Hadarits, F.4
Markó, L.5
Horvatovich, K.6
Oroszlán, T.7
Bagosi, Z.8
Bujtor, Z.9
Gasztonyi, B.10
Wittmann, I.11
Melegh, B.12
-
35
-
-
0033015655
-
Role of ApoCs in lipoprotein metabolism: Functional differences between ApoC1, ApoC2, and ApoC3
-
Jong, M.; Hofker, M.; Havekes, L. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Biol., 1999, 19, 472-84.
-
(1999)
Arterioscler. Thromb. Vasc. Biol
, vol.19
, pp. 472-484
-
-
Jong, M.1
Hofker, M.2
Havekes, L.3
-
36
-
-
9144226803
-
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease
-
Olivieri, O.; Bassi, A.; Stranieri, C.; Trabetti, E.; Martinelli, N.; Pizzolo, F.; Girelli, D.; Friso, S.; Pignatti, P.; Corrocher, R. Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J. Lipid Res., 2003, 44, 2374-81.
-
(2003)
J. Lipid Res
, vol.44
, pp. 2374-2381
-
-
Olivieri, O.1
Bassi, A.2
Stranieri, C.3
Trabetti, E.4
Martinelli, N.5
Pizzolo, F.6
Girelli, D.7
Friso, S.8
Pignatti, P.9
Corrocher, R.10
-
37
-
-
0036739546
-
Apo C-III gene polymorphisms and risk of coronary artery disease
-
Olivieri, O.; Stranieri, C.; Bassi, A.; Zaia, B.; Girelli, D.; Pizzolo, F.; Trabetti, E.; Cheng, S.; Grow, M.; Pignatti, P.; Corrocher, R. ApoC-III gene polymorphisms and risk of coronary artery disease. J. Lipid Res., 2002, 43, 1450-7.
-
(2002)
J. Lipid Res.
, vol.43
, pp. 1450-1457
-
-
Olivieri, O.1
Stranieri, C.2
Bassi, A.3
Zaia, B.4
Girelli, D.5
Pizzolo, F.6
Trabetti, E.7
Cheng, S.8
Grow, M.9
Pignatti, P.10
Corrocher, R.11
-
38
-
-
0026748770
-
Wang, Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III
-
McConathy, W.; Gesquiere, J.; Bass, H.; Tartar, A.; Fruchart, J.; Wang, C. J. Wang, Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. Lipid Res., 1992, 33, 995-1003.
-
(1992)
Lipid Res
, vol.33
, pp. 995-1003
-
-
McConathy, W.1
Gesquiere, J.2
Bass, H.3
Tartar, A.4
Fruchart, J.5
Wang, C.6
Wang, J.7
-
39
-
-
58149262866
-
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection
-
Pollin, T.; Damcott, C.; Shen, H.; Ott, S.; Shelton, J.; Horenstein, R.; Post, W.; McLenithan, J.; Bielak, L.; Peyser, P.; Mitchell, B.; Miller, M.; O'Connell, J.; Shuldiner, A. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science, 2008, 322, 1702-5.
-
(2008)
Science
, vol.322
, pp. 1702-1705
-
-
Pollin, T.1
Damcott, C.2
Shen, H.3
Ott, S.4
Shelton, J.5
Horenstein, R.6
Post, W.7
McLenithan, J.8
Bielak, L.9
Peyser, P.10
Mitchell, B.11
Miller, M.12
O'Connell, J.13
Shuldiner, A.14
-
40
-
-
0037389235
-
Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice
-
Pennacchio, L.; Rubin, E. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Thromb. Vasc Biol., 2003, 23, 529-34.
-
(2003)
Arterioscler Thromb. Vasc Biol
, vol.23
, pp. 529-534
-
-
Pennacchio, L.1
Rubin, E.2
-
41
-
-
10744231400
-
Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease
-
Szalai, C.; Keszei, M.; Duba, J.; Prohászka, Z.; Kozma, G.; Császár, A.; Balogh, S.; Almássy, Z.; Fust, G.; Czinner, A. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis, 2004, 173, 109-14.
-
(2004)
Atherosclerosis
, vol.173
, pp. 109-114
-
-
Szalai, C.1
Keszei, M.2
Duba, J.3
Prohászka, Z.4
Kozma, G.5
Császár, A.6
Balogh, S.7
Almássy, Z.8
Fust, G.9
Czinner, A.10
-
42
-
-
3142581525
-
Apoav reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis
-
Schaap, F.; Rensen, P.; Voshol, P.; Vrins, C.; van der Vliet, H.; Chamuleau, R.; Havekes, L.; Groen, A.; van Dijk, K. Apoav reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J. Biol. Chem., 2004, 279, 27941-7.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 27941-27947
-
-
Schaap, F.1
Rensen, P.2
Voshol, P.3
Vrins, C.4
van der Vliet, H.5
Chamuleau, R.6
Havekes, L.7
Groen, A.8
van Dijk, K.9
-
43
-
-
3042817124
-
Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice
-
Baroukh, N.; Bauge, E.; Akiyama, J.; Chang, J.; Afzal, V.; Fruchart, J.; Rubin, E.; Fruchart-Najib, J.; Pennacchio, L. Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 1297-302.
-
(2004)
Arterioscler. Thromb. Vasc. Biol
, vol.24
, pp. 1297-1302
-
-
Baroukh, N.1
Bauge, E.2
Akiyama, J.3
Chang, J.4
Afzal, V.5
Fruchart, J.6
Rubin, E.7
Fruchart-Najib, J.8
Pennacchio, L.9
-
44
-
-
44449093534
-
Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke
-
Maász, A.; Kisfali, P.; Szolnoki, Z.; Hadarits, F.; Melegh, B. Apolipoprotein A5 gene C56G variant confers risk for the development of large-vessel associated ischemic stroke. J. Neurol., 2008, 255, 649-54.
-
(2008)
J. Neurol
, vol.255
, pp. 649-654
-
-
Maász, A.1
Kisfali, P.2
Szolnoki, Z.3
Hadarits, F.4
Melegh, B.5
-
45
-
-
46849097401
-
Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke
-
Maasz, A.; Kisfali, P.; Jaromi, L.; Horvatovich, K.; Szolnoki, Z.; Csongei, V.; Safrany, E.; Sipeky, C.; Hadarits, F.; Melegh, B. Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke. Circ. J., 2008, 72, 1065-70.
-
(2008)
Circ. J
, vol.72
, pp. 1065-1070
-
-
Maasz, A.1
Kisfali, P.2
Jaromi, L.3
Horvatovich, K.4
Szolnoki, Z.5
Csongei, V.6
Safrany, E.7
Sipeky, C.8
Hadarits, F.9
Melegh, B.10
-
46
-
-
60649103338
-
The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: Association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease
-
Jang, Y.; Paik, J.; Hyun, Y.; Chae, J.; Kim, J.; Choi, J.; Lee, S.; Shin, D.; Ordovas, J.; Lee, J. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin. Chim. Acta, 2009, 402, 83-7.
-
(2009)
Clin. Chim. Acta
, vol.402
, pp. 83-87
-
-
Jang, Y.1
Paik, J.2
Hyun, Y.3
Chae, J.4
Kim, J.5
Choi, J.6
Lee, S.7
Shin, D.8
Ordovas, J.9
Lee, J.10
-
47
-
-
8144225907
-
A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese
-
Bi, N.; Yan, S.; Li, G.; Yin, Z.; Chen, B. A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol. Genet. Metab., 2004, 83, 280-6.
-
(2004)
Mol. Genet. Metab
, vol.83
, pp. 280-286
-
-
Bi, N.1
Yan, S.2
Li, G.3
Yin, Z.4
Chen, B.5
-
48
-
-
30944449042
-
Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan
-
Hsu, L.; Ko, Y.; Chang, C.; Hu, C.; Wu, S.; Teng, M.; Wang, C.; Ho, W.; Ko, Y.; Hsu, T.; Lee, Y. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis, 2006, 185, 143-9
-
(2006)
Atherosclerosis
, vol.185
, pp. 143-149
-
-
Hsu, L.1
Ko, Y.2
Chang, C.3
Hu, C.4
Wu, S.5
Teng, M.6
Wang, C.7
Ho, W.8
Ko, Y.9
Hsu, T.10
Lee, Y.11
-
49
-
-
4143065861
-
APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease
-
Lee, K.; Ayyobi, A.; Frohlich, J.; Hill, J. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. Atherosclerosis, 2004, 176, 165-72.
-
(2004)
Atherosclerosis
, vol.176
, pp. 165-172
-
-
Lee, K.1
Ayyobi, A.2
Frohlich, J.3
Hill, J.4
-
50
-
-
0019321262
-
Cell surface receptor binding of phospholipid. protein complexes containing different ratios of receptor-active and -inactive E apoprotein
-
Pitas, R.; Innerarity, T.; Mahley, R. Cell surface receptor binding of phospholipid. protein complexes containing different ratios of receptor-active and -inactive E apoprotein. J. Biol. Chem., 1980, 255, 5454-60.
-
(1980)
J. Biol. Chem
, vol.255
, pp. 5454-5460
-
-
Pitas, R.1
Innerarity, T.2
Mahley, R.3
-
51
-
-
0038717034
-
Independent effects of the -219 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: The Southampton Atherosclerosis Study
-
Ye, S.; Dunleavey, L.; Bannister, W.; Day, L.; Tapper, W.; Collins, A.; Day, I.; Simpson, I. Independent effects of the -219 G>T and epsilon 2/ epsilon 3/ epsilon 4 polymorphisms in the apolipoprotein E gene on coronary artery disease: the Southampton Atherosclerosis Study. Eur. J. Hum. Genet., 2003, 11, 437-43.
-
(2003)
Eur. J. Hum. Genet
, vol.11
, pp. 437-443
-
-
Ye, S.1
Dunleavey, L.2
Bannister, W.3
Day, L.4
Tapper, W.5
Collins, A.6
Day, I.7
Simpson, I.8
-
52
-
-
0017773790
-
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
-
Utermann, G.; Hees, M.; Steinmetz, A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature, 1977, 269, 604-7.
-
(1977)
Nature
, vol.269
, pp. 604-607
-
-
Utermann, G.1
Hees, M.2
Steinmetz, A.3
-
53
-
-
0023921804
-
Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis
-
Davignon, J.; Roederer, G. Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis Union Med. Can., 1988, 117, 56-61.
-
(1988)
Union Med. Can
, vol.117
, pp. 56-61
-
-
Davignon, J.1
Roederer, G.2
-
54
-
-
0022539782
-
Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects
-
Eto, M.; Watanabe, K.; Ishii, K. Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects. Clin. Genet., 1986, 29, 477-84.
-
(1986)
Clin. Genet
, vol.29
, pp. 477-484
-
-
Eto, M.1
Watanabe, K.2
Ishii, K.3
-
55
-
-
0029818713
-
Apolipoprotein E alleles and risk of coronary disease. A meta-analysis
-
Wilson, P.; Schaefer, E.; Larson, M.; Ordovas, J. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler. Thromb. Vasc. Biol., 1996, 16, 1250-5.
-
(1996)
Arterioscler. Thromb. Vasc. Biol
, vol.16
, pp. 1250-1255
-
-
Wilson, P.1
Schaefer, E.2
Larson, M.3
Ordovas, J.4
Apolipoprotein, E.5
-
56
-
-
0037087052
-
Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review
-
Eichner, J.; Dunn, S.; Perveen, G.; Thompson, D.; Stewart, K.; Stroehla, B. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am. J. Epidemiol., 2002, 155, 487-95.
-
(2002)
Am. J. Epidemiol
, vol.155
, pp. 487-495
-
-
Eichner, J.1
Dunn, S.2
Perveen, G.3
Thompson, D.4
Stewart, K.5
Stroehla, B.6
-
57
-
-
43949110617
-
Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease
-
Granér, M.; Kahri, J.; Varpula, M.; Salonen, R.; Nyyssönen, K.; Jauhiainen, M.; Nieminen, M.; Syvänne, M.; Taskinen, M. Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease. Nutr. Metab. Cardiovasc. Dis., 2008, 18, 271-7.
-
(2008)
Nutr. Metab. Cardiovasc. Dis
, vol.18
, pp. 271-277
-
-
Granér, M.1
Kahri, J.2
Varpula, M.3
Salonen, R.4
Nyyssönen, K.5
Jauhiainen, M.6
Nieminen, M.7
Syvänne, M.8
Taskinen, M.9
Apolipoprotein, E.10
-
58
-
-
0032866820
-
Apolipoprotein E and atherosclerosis: Insight from animal and human studies
-
Davignon, J.; Cohn, J.; Mabile, L.; Bernier, L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin. Chim. Acta, 1999, 286, 115-43.
-
(1999)
Clin. Chim. Acta
, vol.286
, pp. 115-143
-
-
Davignon, J.1
Cohn, J.2
Mabile, L.3
Bernier, L.4
-
59
-
-
3142706539
-
Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease
-
Song, Y.; Stampfer, M.; Liu, S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med., 2004, 141, 137-47.
-
(2004)
Ann. Intern. Med
, vol.141
, pp. 137-147
-
-
Song, Y.1
Stampfer, M.2
Liu, S.3
-
60
-
-
0026672309
-
Regulation of the synthesis, processing and translocation of lipoprotein lipase. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources
-
Braun, J.; Severson, D. Regulation of the synthesis, processing and translocation of lipoprotein lipase. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources. Biochem. J., 1992, 287 (Pt 2), 337-47.
-
(1992)
Biochem. J
, vol.287
, Issue.Pt 2
, pp. 337-347
-
-
Braun, J.1
Severson, D.2
-
61
-
-
0015934581
-
Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources
-
Havel, R.; Fielding, C.; Olivecrona, T.; Shore, V.; Fielding, P.; Egelrud, T. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources. Biochemistry, 1973, 12, 1828-33.
-
(1973)
Biochemistry
, vol.12
, pp. 1828-1833
-
-
Havel, R.1
Fielding, C.2
Olivecrona, T.3
Shore, V.4
Fielding, P.5
Egelrud, T.6
-
62
-
-
0036906508
-
Lipoprotein lipase: Genetics, lipid uptake, and regulation
-
Merkel, M.; Eckel, R.; Goldberg, I. Lipoprotein lipase: genetics, lipid uptake, and regulation. J. Lipid Res., 2002, 43, 1997-2006.
-
(2002)
J. Lipid Res
, vol.43
, pp. 1997-2006
-
-
Merkel, M.1
Eckel, R.2
Goldberg, I.3
-
63
-
-
0031955802
-
Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: The European Atherosclerosis Research Study (EARS)
-
Humphries, S.; Nicaud, V.; Margalef, J.; Tiret, L.; Talmud, P. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler. Thromb. Vasc. Biol., 1998, 18, 526-34.
-
(1998)
Arterioscler. Thromb. Vasc. Biol
, vol.18
, pp. 526-534
-
-
Humphries, S.1
Nicaud, V.2
Margalef, J.3
Tiret, L.4
Talmud, P.5
-
64
-
-
0027393983
-
High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis
-
Renier, G.; Skamene, E.; DeSanctis, J.; Radzioch, D. High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. Arterioscler. Thromb., 1993, 13, 190-6.
-
(1993)
Arterioscler. Thromb
, vol.13
, pp. 190-196
-
-
Renier, G.1
Skamene, E.2
Desanctis, J.3
Radzioch, D.4
-
65
-
-
0034072181
-
Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: Role of peripheral factors
-
Sartippour, M.; Renier, G. Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors. Diabetes, 2000, 49, 597-602.
-
(2000)
Diabetes
, vol.49
, pp. 597-602
-
-
Sartippour, M.1
Renier, G.2
-
66
-
-
0031810437
-
Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice
-
Semenkovich, C.; Coleman, T.; Daugherty, A. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice. J. Lipid Res., 1998, 39, 1141-51.
-
(1998)
J. Lipid Res
, vol.39
, pp. 1141-1151
-
-
Semenkovich, C.1
Coleman, T.2
Daugherty, A.3
-
67
-
-
0033536024
-
Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis
-
Wittrup, H.; Tybjaerg-Hansen, A.; Nordestgaard, B. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation, 1999, 99, 2901-7.
-
(1999)
Circulation
, vol.99
, pp. 2901-2907
-
-
Wittrup, H.1
Tybjaerg-Hansen, A.2
Nordestgaard, B.3
-
68
-
-
0030769243
-
Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis
-
Huang, P.; Kostulas, K.; Huang, W.; Crisby, M.; Kostulas, V.; Hillert, J. Lipoprotein lipase gene polymorphisms in ischaemic stroke and carotid stenosis. Eur. J. Clin. Invest., 1997, 27, 740-2.
-
(1997)
Eur. J. Clin. Invest
, vol.27
, pp. 740-742
-
-
Huang, P.1
Kostulas, K.2
Huang, W.3
Crisby, M.4
Kostulas, V.5
Hillert, J.6
-
69
-
-
0032722471
-
Two common mutations (D9N, N291S) in lipoprotein lipase: A cumulative analysis of their influence on plasma lipids and lipoproteins in men and women
-
Kastelein, J.; Ordovas, J.; Wittekoek, M.; Pimstone, S.; Wilson, W.; Gagné, S.; Larson, M.; Schaefer, E.; Boer, J.; Gerdes, C.; Hayden, M. Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women. Clin. Genet., 1999, 56, 297-305.
-
(1999)
Clin. Genet
, vol.56
, pp. 297-305
-
-
Kastelein, J.1
Ordovas, J.2
Wittekoek, M.3
Pimstone, S.4
Wilson, W.5
Gagné, S.6
Larson, M.7
Schaefer, E.8
Boer, J.9
Gerdes, C.10
Hayden, M.11
-
70
-
-
0033021054
-
Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study
-
Wittrup, H.; Tybjaerg-Hansen, A.; Steffensen, R.; Deeb, S.; Brunzell, J.; Jensen, G.; Nordestgaard, B. Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study. Arterioscler. Thromb. Vasc. Biol., 1999, 19, 1535-40.
-
(1999)
Arterioscler. Thromb. Vasc. Biol
, vol.19
, pp. 1535-1540
-
-
Wittrup, H.1
Tybjaerg-Hansen, A.2
Steffensen, R.3
Deeb, S.4
Brunzell, J.5
Jensen, G.6
Nordestgaard, B.7
-
71
-
-
0034705084
-
A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men
-
Wittrup, H.; Nordestgaard, B.; Sillesen, H.; Schnohr, P.; TybjaergHansen, A. A common mutation in lipoprotein lipase confers a 2-fold increase in risk of ischemic cerebrovascular disease in women but not in men. Circulation, 2000, 101, 2393-7.
-
(2000)
Circulation
, vol.101
, pp. 2393-2397
-
-
Wittrup, H.1
Nordestgaard, B.2
Sillesen, H.3
Schnohr, P.4
Tybjaerghansen, A.5
-
72
-
-
0030745465
-
Lipoprotein lipase gene variants and risk of coronary disease: A quantitative analysis of population-based studies
-
Hokanson, J. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int. J. Clin. Lab. Res., 1997, 27, 24-34.
-
(1997)
Int. J. Clin. Lab. Res
, vol.27
, pp. 24-34
-
-
Hokanson, J.1
-
73
-
-
0032792469
-
A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: The Framingham Offspring Study
-
Gagné, S.; Larson, M.; Pimstone, S.; Schaefer, E.; Kastelein, J.; Wilson, P.; Ordovas, J.; Hayden, M. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin. Genet., 1999, 55, 450-4.
-
(1999)
Clin. Genet
, vol.55
, pp. 450-454
-
-
Gagné, S.1
Larson, M.2
Pimstone, S.3
Schaefer, E.4
Kastelein, J.5
Wilson, P.6
Ordovas, J.7
Hayden, M.8
-
74
-
-
0027974106
-
Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses
-
Peacock, R.; Hamsten, A.; Johansson, J.; Nilsson-Ehle, P.; Humphries, S. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses. Clin. Genet., 1994, 46, 273-82.
-
(1994)
Clin. Genet
, vol.46
, pp. 273-282
-
-
Peacock, R.1
Hamsten, A.2
Johansson, J.3
Nilsson-Ehle, P.4
Humphries, S.5
-
75
-
-
0029592586
-
Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease
-
Zhang, Q.; Cavanna, J.; Winkelman, B.; Shine, B.; Gross, W.; Marz, W.; Galton, D. Common genetic variants of lipoprotein lipase that relate to lipid transport in patients with premature coronary artery disease. Clin. Genet., 1995, 48, 293-8.
-
(1995)
Clin. Genet
, vol.48
, pp. 293-298
-
-
Zhang, Q.1
Cavanna, J.2
Winkelman, B.3
Shine, B.4
Gross, W.5
Marz, W.6
Galton, D.7
-
76
-
-
0028883699
-
Lipoprotein lipase gene polymorphisms: Associations with myocardial infarction and lipoprotein levels, the ECTIM study
-
Jemaa, R.; Fumeron, F.; Poirier, O.; Lecerf, L.; Evans, A.; Arveiler, D.; Luc, G.; Cambou, J.; Bard, J.; Fruchart, J. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study J. Lipid Res., 1995, 36, 2141-2146.
-
(1995)
J. Lipid Res
, vol.36
, pp. 2141-2146
-
-
Jemaa, R.1
Fumeron, F.2
Poirier, O.3
Lecerf, L.4
Evans, A.5
Arveiler, D.6
Luc, G.7
Cambou, J.8
Bard, J.9
Fruchart, J.10
-
77
-
-
0032171256
-
Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort
-
Sass, C.; Zannad, F.; Herbeth, B.; Salah, D.; Chapet, O.; Siest, G.; Visvikis, S. Apolipoprotein E4, lipoprotein lipase C447 and angiotensin-I converting enzyme deletion alleles were not associated with increased wall thickness of carotid and femoral arteries in healthy subjects from the Stanislas cohort. Atherosclerosis, 1998, 140, 89-95.
-
(1998)
Atherosclerosis
, vol.140
, pp. 89-95
-
-
Sass, C.1
Zannad, F.2
Herbeth, B.3
Salah, D.4
Chapet, O.5
Siest, G.6
Visvikis, S.7
-
78
-
-
0028174814
-
DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population
-
Mattu, R.; Needham, E.; Morgan, R.; Rees, A.; Hackshaw, A.; Stocks, J.; Elwood, P.; Galton, D. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler. Thromb., 1994, 14, 1090-7.
-
(1994)
Arterioscler. Thromb.
, vol.14
, pp. 1090-1097
-
-
Mattu, R.1
Needham, E.2
Morgan, R.3
Rees, A.4
Hackshaw, A.5
Stocks, J.6
Elwood, P.7
Galton, D.D.N.A.8
-
79
-
-
0031442577
-
A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro
-
Hall, S.; Chu, G.; Miller, G.; Cruickshank, K.; Cooper, J.; Humphries, S.; Talmud, P. A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 1969-76.
-
(1997)
Arterioscler. Thromb. Vasc. Biol
, vol.17
, pp. 1969-1976
-
-
Hall, S.1
Chu, G.2
Miller, G.3
Cruickshank, K.4
Cooper, J.5
Humphries, S.6
Talmud, P.A.7
-
80
-
-
0031810538
-
PL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics
-
Talmud, P.; Hall, S.; Holleran, S.; Ramakrishnan, R.; Ginsberg, H.; Humphries, S. J. PL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics. Lipid. Res., 1998, 39, 1189-96.
-
(1998)
Lipid. Res
, vol.39
, pp. 1189-1196
-
-
Talmud, P.1
Hall, S.2
Holleran, S.3
Ramakrishnan, R.4
Ginsberg, H.5
Humphries, S.J.6
-
81
-
-
12444316058
-
Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis
-
Saika, Y.; Sakai, N.; Takahashi, M.; Maruyama, T.; Kihara, S.; Ouchi, N.; Ishigami, M.; Hiraoka, H.; Nakamura, T.; Yamashita, S.; Matsuzawa, Y. Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis. Eur. J. Clin. Invest., 2003, 33, 216-22.
-
(2003)
Eur. J. Clin. Invest
, vol.33
, pp. 216-222
-
-
Saika, Y.1
Sakai, N.2
Takahashi, M.3
Maruyama, T.4
Kihara, S.5
Ouchi, N.6
Ishigami, M.7
Hiraoka, H.8
Nakamura, T.9
Yamashita, S.10
Matsuzawa, Y.11
Novel, L.P.L.12
-
82
-
-
57849135455
-
Retinoid X receptor and peroxisome proliferator-activated receptorgamma agonists cooperate to inhibit matrix metalloproteinase gene expression. Arthritis Res
-
Burrage, P.; Schmucker, A.; Ren, Y.; Sporn, M.; Brinckerhoff, C. Retinoid X receptor and peroxisome proliferator-activated receptorgamma agonists cooperate to inhibit matrix metalloproteinase gene expression. Arthritis Res. Ther., 2008, 10, R139.
-
(2008)
Arthritis Res. Ther
, vol.10
-
-
Burrage, P.1
Schmucker, A.2
Ren, Y.3
Sporn, M.4
Brinckerhoff, C.5
Retinoid, X.6
-
83
-
-
3242733220
-
Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins
-
Schachtrup, C.; Emmler, T.; Bleck, B.; Sandqvist, A.; Spener, F. Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins. Biochem. J., 2004, 382, 239-45.
-
(2004)
Biochem. J
, vol.382
, pp. 239-245
-
-
Schachtrup, C.1
Emmler, T.2
Bleck, B.3
Sandqvist, A.4
Spener, F.5
-
84
-
-
58149466606
-
PPARs mediate lipid signaling in inflammation and cancer
-
134059
-
Michalik, L.; Wahli, W. PPARs mediate lipid signaling in inflammation and cancer. PPAR Res., 2008, 2008, 134059.
-
(2008)
PPAR Res
, pp. 2008
-
-
Michalik, L.1
Wahli, W.2
-
85
-
-
26444588777
-
Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population
-
Ghoussaini, M.; Meyre, D.; Lobbens, S.; Charpentier, G.; Clément, K.; Charles, M.; Tauber, M.; Weill, J.; Froguel, P. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med. Genet., 2005, 6, 11.
-
(2005)
BMC Med. Genet
, vol.6
, pp. 11
-
-
Ghoussaini, M.1
Meyre, D.2
Lobbens, S.3
Charpentier, G.4
Clément, K.5
Charles, M.6
Tauber, M.7
Weill, J.8
Froguel, P.9
-
86
-
-
67649093997
-
PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes
-
Vogel, U.; Segel, S.; Dethlefsen, C.; Tjønneland, A.; Saber, A.; Wallin, H.; Jensen, M.; Schmidt, E.; Andersen, P.; Overvad, K. PPARgamma Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes. BMC Med. Genet., 2009, 10, 52.
-
(2009)
BMC Med. Genet
, vol.10
, pp. 52
-
-
Vogel, U.1
Segel, S.2
Dethlefsen, C.3
Tjønneland, A.4
Saber, A.5
Wallin, H.6
Jensen, M.7
Schmidt, E.8
Andersen, P.9
Overvad, K.10
-
87
-
-
42749099527
-
M. 'Striking the right balance' in targeting PPARgamma in the metabolic syndrome: Novel insights from human genetic studies
-
Gurnell
-
Gurnell, M. 'Striking the right balance' in targeting PPARgamma in the metabolic syndrome: novel insights from human genetic studies. PPAR Res., 2007, 2007, 83593.
-
(2007)
PPAR Res
, vol.2007
, pp. 83593
-
-
-
88
-
-
72449192922
-
PPARgamma2 polymorphism and human health
-
849538
-
He, W. PPARgamma2 polymorphism and human health. PPAR Res., 2009, 2009, 849538.
-
(2009)
PPAR Res
, pp. 2009
-
-
He, W.1
-
89
-
-
75149124430
-
ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses
-
Yvan-Charvet, L.; Wang, N.; Tall, A. ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler. Thromb. Vasc. Biol., 2010, 30, 139-43.
-
(2010)
Arterioscler. Thromb. Vasc. Biol
, vol.30
, pp. 139-143
-
-
Yvan-Charvet, L.1
Wang, N.2
Tall, A.3
-
90
-
-
33947311656
-
Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype
-
Mantaring, M.; Rhyne, J.; Ho Hong, S.; Miller, M. Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype. Transl. Res., 2007, 149, 205-10.
-
(2007)
Transl. Res
, vol.149
, pp. 205-210
-
-
Mantaring, M.1
Rhyne, J.2
Ho Hong, S.3
Miller, M.4
-
91
-
-
33750927892
-
ATP-Binding cassette cholesterol transporters and cardiovascular disease
-
Oram, J.; Vaughan, A. ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ. Res., 2006, 99, 1031-1043.
-
(2006)
Circ. Res
, vol.99
, pp. 1031-1043
-
-
Oram, J.1
Vaughan, A.2
-
92
-
-
26844536636
-
Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population
-
Frikke-Schmidt, R.; Nordestgaard, B.; Schnohr, P.; Steffensen, R.; Tybjaerg-Hansen, A. Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population. J. Am. Coll. Cardiol., 2005, 46, 1516-1520.
-
(2005)
J. Am. Coll. Cardiol
, vol.46
, pp. 1516-1520
-
-
Frikke-Schmidt, R.1
Nordestgaard, B.2
Schnohr, P.3
Steffensen, R.4
Tybjaerg-Hansen, A.5
-
93
-
-
37549059892
-
Genetic variation in ABCA1 predicts ischemic heart disease in the general population
-
Frikke-Schmidt, R.; Nordestgaard, B.; Jensen, G.; Steffensen, R.; Tybjaerg-Hansen, A. Genetic variation in ABCA1 predicts ischemic heart disease in the general population. Arterioscler. Thromb. Vasc. Biol., 2008, 28, 180-6.
-
(2008)
Arterioscler. Thromb. Vasc. Biol
, vol.28
, pp. 180-186
-
-
Frikke-Schmidt, R.1
Nordestgaard, B.2
Jensen, G.3
Steffensen, R.4
Tybjaerg-Hansen, A.5
-
94
-
-
67649262236
-
The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes
-
Tang, C.; Oram, J. The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes. Biochim. Biophys. Acta, 2009, 1791, 563-72.
-
(2009)
Biochim. Biophys. Acta
, vol.1791
, pp. 563-572
-
-
Tang, C.1
Oram, J.2
-
95
-
-
40749127658
-
Association of the ATP-binding cassette transporter A1 R230C variant with early-onset type 2 diabetes in a Mexican population
-
Villarreal-Molina, M.; Flores-Dorantes, M.; Arellano-Campos, O.; Villalobos-Comparan, M.; Rodríguez-Cruz, M.; Miliar-García, A.; Huertas-Vazquez, A.; Menjivar, M.; Romero-Hidalgo, S.; Wacher, N.; Tusie-Luna, M.; Cruz, M.; Aguilar-Salinas, C.; Canizales-Quinteros, S. Association of the ATP-binding cassette transporter A1 R230C variant with early-onset type 2 diabetes in a Mexican population. Diabetes, 2008, 57, 509-13.
-
(2008)
Diabetes
, vol.57
, pp. 509-513
-
-
Villarreal-Molina, M.1
Flores-Dorantes, M.2
Arellano-Campos, O.3
Villalobos-Comparan, M.4
Rodríguez-Cruz, M.5
Miliar-García, A.6
Huertas-Vazquez, A.7
Menjivar, M.8
Romero-Hidalgo, S.9
Wacher, N.10
Tusie-Luna, M.11
Cruz, M.12
Aguilar-Salinas, C.13
Canizales-Quinteros, S.14
-
96
-
-
33646801910
-
R1615P: A novel mutation in ABCA1 associated with low levels of HDL and type II diabetes mellitus
-
Saleheen, D.; Nazir, A.; Khanum, S.; Haider, S.; Frossard, P. R1615P: a novel mutation in ABCA1 associated with low levels of HDL and type II diabetes mellitus. Int. J. Cardiol., 2006, 110, 259-260.
-
(2006)
Int. J. Cardiol
, vol.110
, pp. 259-260
-
-
Saleheen, D.1
Nazir, A.2
Khanum, S.3
Haider, S.4
Frossard, P.5
-
97
-
-
33645788381
-
Application of a sensitive collection heuristic for very large protein families: Evolutionary relationship between adipose triglyceride lipase (ATGL) and classic mammalian lipases
-
Schneider, G.; Neuberger, G.; Wildpaner, M.; Tian, S.; Berezovsky, I.; Eisenhaber, F. Application of a sensitive collection heuristic for very large protein families: evolutionary relationship between adipose triglyceride lipase (ATGL) and classic mammalian lipases. BMC Bioinformatics, 2006, 7, 164.
-
(2006)
BMC Bioinformatics
, vol.7
, pp. 164
-
-
Schneider, G.1
Neuberger, G.2
Wildpaner, M.3
Tian, S.4
Berezovsky, I.5
Eisenhaber, F.6
-
98
-
-
33745294013
-
The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes
-
Schoenborn, V.; Heid, I.; Vollmert, C.; Lingenhel, A.; Adams, T.; Hopkins, P.; Illig, T.; Zimmermann, R.; Zechner, R.; Hunt, S.; Kronenberg, F. The ATGL gene is associated with free fatty acids, triglycerides, and type 2 diabetes. Diabetes, 2006, 55, 1270-5.
-
(2006)
Diabetes
, vol.55
, pp. 1270-1275
-
-
Schoenborn, V.1
Heid, I.2
Vollmert, C.3
Lingenhel, A.4
Adams, T.5
Hopkins, P.6
Illig, T.7
Zimmermann, R.8
Zechner, R.9
Hunt, S.10
Kronenberg, F.11
-
99
-
-
0028057583
-
Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes
-
Vaxillaire, M.; Vionnet, N.; Vigouroux, C.; Sun, F.; Espinosa, R. r.; Lebeau, M.; Stoffel M.; Lehto, M.; Beckmann, J.; Detheux, M. Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes, 1994, 43, 389-95.
-
(1994)
Diabetes
, vol.43
, pp. 389-395
-
-
Vaxillaire, M.1
Vionnet, N.2
Vigouroux, C.3
Sun, F.4
Espinosa, R.R.5
Lebeau, M.6
Stoffel, M.7
Lehto, M.8
Beckmann, J.9
Detheux, M.10
-
100
-
-
0032054857
-
Organization of the human glucokinase regulator gene GCKR
-
Hayward, B.; Dunlop, N.; Intody, S.; Leek, J.; Markham, A.; Warner, J.; Bonthron, D. Organization of the human glucokinase regulator gene GCKR. Genomics, 1998, 49, 137-42.
-
(1998)
Genomics
, vol.49
, pp. 137-142
-
-
Hayward, B.1
Dunlop, N.2
Intody, S.3
Leek, J.4
Markham, A.5
Warner, J.6
Bonthron, D.7
-
101
-
-
0029347069
-
Human glucokinase regulatory protein (GCKR): CDNA and genomic cloning, complete primary structure, and chromosomal localization
-
Warner, J.; Leek, J.; Intody, S.; Markham, A.; Bonthron, D. Human glucokinase regulatory protein (GCKR): cDNA and genomic cloning, complete primary structure, and chromosomal localization. Mamm. Genome, 1995, 6, 532-6.
-
(1995)
Mamm. Genome
, vol.6
, pp. 532-536
-
-
Warner, J.1
Leek, J.2
Intody, S.3
Markham, A.4
Bonthron, D.5
-
102
-
-
0030154852
-
Co-localization of the ketohexokinase and glucokinase regulator genes to a 500-kb region of chromosome 2p23
-
Hayward, B.; Fantes, J.; Warner, J.; Intody, S.; Leek, J.; Markham, A.; Bonthron, D. Co-localization of the ketohexokinase and glucokinase regulator genes to a 500-kb region of chromosome 2p23. Mamm. Genome, 1996, 7, 454-8.
-
(1996)
Mamm. Genome
, vol.7
, pp. 454-458
-
-
Hayward, B.1
Fantes, J.2
Warner, J.3
Intody, S.4
Leek, J.5
Markham, A.6
Bonthron, D.7
-
103
-
-
0033432692
-
Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: A sequestration mechanism in metabolic regulation
-
Farrelly, D.; Brown, K.; Tieman, A.; Ren, J.; Lira, S.; Hagan, D.; Gregg, R.; Mookhtiar, K.; Hariharan, N. Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 14511-6.
-
(1999)
Proc. Natl. Acad. Sci. U.S.A
, vol.96
, pp. 14511-14516
-
-
Farrelly, D.1
Brown, K.2
Tieman, A.3
Ren, J.4
Lira, S.5
Hagan, D.6
Gregg, R.7
Mookhtiar, K.8
Hariharan, N.9
-
104
-
-
0034677787
-
Characterization of glucokinase regulatory protein-deficient mice
-
Grimsby, J.; Coffey, J.; Dvorozniak, M.; Magram, J.; Li, G.; Matschinsky, F.; Shiota, C.; Kaur, S.; Magnuson, M.; Grippo, J. Characterization of glucokinase regulatory protein-deficient mice. J. Biol. Chem., 2000, 275, 7826-31.
-
(2000)
J. Biol. Chem
, vol.275
, pp. 7826-7831
-
-
Grimsby, J.1
Coffey, J.2
Dvorozniak, M.3
Magram, J.4
Li, G.5
Matschinsky, F.6
Shiota, C.7
Kaur, S.8
Magnuson, M.9
Grippo, J.10
-
105
-
-
70349980881
-
The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver
-
Beer, N.; Tribble, N.; McCulloch, L.; Roos, C.; Johnson, P.; Orhomelander, M.; Gloyn, A. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum. Mol. Genet., 2009, 18, 4081-8.
-
(2009)
Hum. Mol. Genet
, vol.18
, pp. 4081-4088
-
-
Beer, N.1
Tribble, N.2
McCulloch, L.3
Roos, C.4
Johnson, P.5
Orhomelander, M.6
Gloyn, A.7
-
106
-
-
50949132578
-
The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population
-
Vaxillaire, M.; Cavalcanti-Proença, C.; Dechaume, A.; Tichet, J.; Marre, M.; Balkau, B.; Froguel, P. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Diabetes, 2008, 57, 2253-7.
-
(2008)
Diabetes
, vol.57
, pp. 2253-2257
-
-
Vaxillaire, M.1
Cavalcanti-Proença, C.2
Dechaume, A.3
Tichet, J.4
Marre, M.5
Balkau, B.6
Froguel, P.7
-
107
-
-
77950189510
-
Functional variants of glucokinase regulatory protein and apolipoprotein A5 genes in ischemic stroke
-
Járomi, L.; Csöngei, V.; Polgár, N.; Szolnoki, Z.; Maász, A.; Horvatovich, K.; Faragó, B.; Sipeky, C.; Sáfrány, E.; Magyari, L.; Kisfali, P.; Mohás, M.; Janicsek, I.; Lakner, L.; Melegh, B. Functional variants of glucokinase regulatory protein and apolipoprotein A5 genes in ischemic stroke. J. Mol. Neurosci., 2010, 41(1), 121-8.
-
(2010)
J. Mol. Neurosci
, vol.41
, Issue.1
, pp. 121-128
-
-
Járomi, L.1
Csöngei, V.2
Polgár, N.3
Szolnoki, Z.4
Maász, A.5
Horvatovich, K.6
Faragó, B.7
Sipeky, C.8
Sáfrány, E.9
Magyari, L.10
Kisfali, P.11
Mohás, M.12
Janicsek, I.13
Lakner, L.14
Melegh, B.15
-
108
-
-
0014216991
-
Enzymatic synthesis of the proteinhexosamine linkage in sheep submaxillary mucin
-
McGuire, E.; Roseman, S. Enzymatic synthesis of the proteinhexosamine linkage in sheep submaxillary mucin. J. Biol. Chem., 1967, 242, 3745-7.
-
(1967)
J. Biol. Chem
, vol.242
, pp. 3745-3747
-
-
McGuire, E.1
Roseman, S.2
-
109
-
-
50849100090
-
Polygenic Triglyceride Level Affecting Shared Susceptibility Genes determinants of severe hypertriglyceridemia
-
Wang, J.; Ban, M.; Zou, G.; Cao, H.; Lin, T.; Kennedy, B.; Anand, S.; Yusuf, S.; Huff, M.; Pollex, R.; Hegele, R. Polygenic Triglyceride Level Affecting Shared Susceptibility Genes determinants of severe hypertriglyceridemia. Hum. Mol. Genet., 2008, 17, 2894-9.
-
(2008)
Hum. Mol. Genet
, vol.17
, pp. 2894-2899
-
-
Wang, J.1
Ban, M.2
Zou, G.3
Cao, H.4
Lin, T.5
Kennedy, B.6
Anand, S.7
Yusuf, S.8
Huff, M.9
Pollex, R.10
Hegele, R.11
-
110
-
-
33749407193
-
ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver
-
Ma, L.; Robinson, L.; Towle, H. ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J. Biol. Chem., 2006, 281, 28721-30.
-
(2006)
J. Biol. Chem
, vol.281
, pp. 28721-30
-
-
Ma, L.1
Robinson, L.2
Towle, H.3
-
111
-
-
33746536677
-
Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis
-
Uyeda, K.; Repa, J. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab., 2006, 4, 107-10.
-
(2006)
Cell Metab
, vol.4
, pp. 107-110
-
-
Uyeda, K.1
Repa, J.2
-
112
-
-
67449128717
-
Large scale replication analysis of loci associated with lipid concentrations in a Japanese population
-
Nakayama, K.; Bayasgalan, T.; Yamanaka, K.; Kumada, M.; Gotoh, T.; Utsumi, N.; Yanagisawa, Y.; Okayama, M.; Kajii, E.; Ishibashi, S.; Iwamoto, S. Large scale replication analysis of loci associated with lipid concentrations in a Japanese population. J. Med. Genet., 2009, 46, 370-4.
-
(2009)
J. Med. Genet
, vol.46
, pp. 370-374
-
-
Nakayama, K.1
Bayasgalan, T.2
Yamanaka, K.3
Kumada, M.4
Gotoh, T.5
Utsumi, N.6
Yanagisawa, Y.7
Okayama, M.8
Kajii, E.9
Ishibashi, S.10
Iwamoto, S.11
-
113
-
-
67649435687
-
G771C polymorphism in the MLXIPL gene is associated with a risk of coronary artery disease in the chinese: A case-control study
-
Pan, L.; Chen, Y.; Huang, H.; Zhang, L.; Liu, R.; Li, X.; Qiang, O.; Zeng, Z. G771C polymorphism in the MLXIPL gene is associated with a risk of coronary artery disease in the chinese: a case-control study. Cardiology, 2009, 114, 174-8.
-
(2009)
Cardiology
, vol.114
, pp. 174-178
-
-
Pan, L.1
Chen, Y.2
Huang, H.3
Zhang, L.4
Liu, R.5
Li, X.6
Qiang, O.7
Zeng, Z.8
-
114
-
-
57049094377
-
MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe
-
Vrablik, M.; Ceska, R.; Adamkova, V.; Peasey, A.; Pikhart, H.; Kubinova, R.; Marmot, M.; Bobak, M.; Hubacek, J. MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe. Hum. Genet., 2008, 124, 553-5.
-
(2008)
Hum. Genet
, vol.124
, pp. 553-555
-
-
Vrablik, M.1
Ceska, R.2
Adamkova, V.3
Peasey, A.4
Pikhart, H.5
Kubinova, R.6
Marmot, M.7
Bobak, M.8
Hubacek, J.9
-
115
-
-
0036478902
-
Angptl3 regulates lipid metabolism in mice
-
Koishi, R.; Ando, Y.; Ono, M.; Shimamura, M.; Yasumo, H.; Fujiwara, T.; Horikoshi, H.; Furukawa, H. Angptl3 regulates lipid metabolism in mice. Nat. Genet., 2002, 30, 151-7.
-
(2002)
Nat. Genet
, vol.30
, pp. 151-157
-
-
Koishi, R.1
Ando, Y.2
Ono, M.3
Shimamura, M.4
Yasumo, H.5
Fujiwara, T.6
Horikoshi, H.7
Furukawa, H.8
-
116
-
-
0033572420
-
Identification of a mammalian angiopoietin-related protein expressed specifically in liver
-
Conklin, D.; Gilbertson, D.; Taft, D.; Maurer, M.; Whitmore, T.; Smith, D.; Walker, K.; Chen, L.; Wattler, S.; Nehls, M.; Lewis, K. Identification of a mammalian angiopoietin-related protein expressed specifically in liver. Genomics, 1999, 62, 477-82.
-
(1999)
Genomics
, vol.62
, pp. 477-482
-
-
Conklin, D.1
Gilbertson, D.2
Taft, D.3
Maurer, M.4
Whitmore, T.5
Smith, D.6
Walker, K.7
Chen, L.8
Wattler, S.9
Nehls, M.10
Lewis, K.11
-
117
-
-
0142149169
-
Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo
-
Ono, M.; Shimizugawa, T.; Shimamura, M.; Yoshida, K.; Nojisakikawa, C.; Ando, Y.; Koishi, R.; Furukawa, H. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J. Biol. Chem., 2003, 278, 41804-9.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 41804-41809
-
-
Ono, M.1
Shimizugawa, T.2
Shimamura, M.3
Yoshida, K.4
Nojisakikawa, C.5
Ando, Y.6
Koishi, R.7
Furukawa, H.8
-
118
-
-
0037072759
-
ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase
-
Shimizugawa, T.; Ono, M.; Shimamura, M.; Yoshida, K.; Ando, Y.; Koishi, R.; Ueda, K.; Inaba, T.; Minekura, H.; Kohama, T.; Furukawa, H. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem., 2002, 277, 33742-8.
-
(2002)
J. Biol. Chem
, vol.277
, pp. 33742-33748
-
-
Shimizugawa, T.1
Ono, M.2
Shimamura, M.3
Yoshida, K.4
Ando, Y.5
Koishi, R.6
Ueda, K.7
Inaba, T.8
Minekura, H.9
Kohama, T.10
Furukawa, H.11
-
119
-
-
0036847133
-
Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase
-
Yoshida, K.; Shimizugawa, T.; Ono, M.; Furukawa, H. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res., 2002, 43, 1770-2.
-
(2002)
J. Lipid Res
, vol.43
, pp. 1770-1772
-
-
Yoshida, K.1
Shimizugawa, T.2
Ono, M.3
Furukawa, H.4
-
120
-
-
0038353226
-
Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor
-
Inaba, T.; Matsuda, M.; Shimamura, M.; Takei, N.; Terasaka, N.; Ando, Y.; Yasumo, H.; Koishi, R.; Makishima, M.; Shimomura, I. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J. Biol. Chem., 2003, 278, 21344-51.
-
(2003)
J. Biol. Chem
, vol.278
, pp. 21344-51
-
-
Inaba, T.1
Matsuda, M.2
Shimamura, M.3
Takei, N.4
Terasaka, N.5
Ando, Y.6
Yasumo, H.7
Koishi, R.8
Makishima, M.9
Shimomura, I.10
-
121
-
-
0037237779
-
Regulation of the angiopoietin-like protein 3 gene by LXR
-
Kaplan, R.; Zhang, T.; Hernandez, M.; Gan, F.; Wright, S.; Waters, M.; Cai, T. Regulation of the angiopoietin-like protein 3 gene by LXR. J. Lipid Res., 2003, 44, 136-43.
-
(2003)
J. Lipid Res
, vol.44
, pp. 136-143
-
-
Kaplan, R.1
Zhang, T.2
Hernandez, M.3
Gan, F.4
Wright, S.5
Waters, M.6
Cai, T.7
-
122
-
-
61749090233
-
Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans
-
Romeo, S.; Yin, W.; Kozlitina, J.; Pennacchio, L.; Boerwinkle, E.; Hobbs, H.; Cohen, J. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest., 2009, 119, 70-9.
-
(2009)
J. Clin. Invest
, vol.119
, pp. 70-79
-
-
Romeo, S.1
Yin, W.2
Kozlitina, J.3
Pennacchio, L.4
Boerwinkle, E.5
Hobbs, H.6
Cohen, J.7
-
123
-
-
50049098131
-
Identification of a novel locus for triglyceride on chromosome 1p31-32 in families with premature CAD and MI
-
Seidelmann, S.; Li, L.; Shen, G.; Topol, E.; Wang, Q. Identification of a novel locus for triglyceride on chromosome 1p31-32 in families with premature CAD and MI. J. Lipid. Res., 2008, 49, 1034-8.
-
(2008)
J. Lipid. Res
, vol.49
, pp. 1034-1038
-
-
Seidelmann, S.1
Li, L.2
Shen, G.3
Topol, E.4
Wang, Q.5
-
124
-
-
26844540456
-
Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: Regulation of triglyceride metabolism
-
Köster, A.; Chao, Y.; Mosior, M.; Ford, A.; Gonzalez-DeWhitt, P.; Hale, J.; Li, D.; Qiu, Y.; Fraser, C.; Yang, D.; Heuer, J.; Jaskunas, S.; Eacho, P. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology, 2005, 146, 4943-50.
-
(2005)
Endocrinology
, vol.146
, pp. 4943-4950
-
-
Köster, A.1
Chao, Y.2
Mosior, M.3
Ford, A.4
Gonzalez-Dewhitt, P.5
Hale, J.6
Li, D.7
Qiu, Y.8
Fraser, C.9
Yang, D.10
Heuer, J.11
Jaskunas, S.12
Eacho, P.13
-
125
-
-
0037653269
-
One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist
-
Johnson, K.; Farley, D.; Hu, S.; Terkeltaub, R. One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist. Arthritis Rheum., 2003, 48, 1302-14.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 1302-1314
-
-
Johnson, K.1
Farley, D.2
Hu, S.3
Terkeltaub, R.4
-
126
-
-
64349100189
-
Polymorphisms at newly identified lipid-associated loci are associated with blood lipids and cardiovascular disease in an Asian Malay population
-
Tai, E.; Sim, X.; Ong, T.; Wong, T.; Saw, S.; Aung, T.; Kathiresan, S.; Orho-Melander, M.; Ordovas, J.; Tan, J.; Seielstad, M. Polymorphisms at newly identified lipid-associated loci are associated with blood lipids and cardiovascular disease in an Asian Malay population. J. Lipid Res., 2009, 50, 514-20.
-
(2009)
J. Lipid Res
, vol.50
, pp. 514-520
-
-
Tai, E.1
Sim, X.2
Ong, T.3
Wong, T.4
Saw, S.5
Aung, T.6
Kathiresan, S.7
Orho-Melander, M.8
Ordovas, J.9
Tan, J.10
Seielstad, M.11
-
127
-
-
5644285309
-
Human tribbles, a protein family controlling mitogen-activated protein kinase cascades
-
Kiss-Toth, E.; Bagstaff, S.; Sung, H.; Jozsa, V.; Dempsey, C.; Caunt, J.; Oxley, K.; Wyllie, D.; Polgar, T.; Harte, M.; O'neill, L.; Qwarnstrom, E.; Dower, S. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J. Biol. Chem., 2004, 279, 42703-8.
-
(2004)
J. Biol. Chem
, vol.279
, pp. 42703-42708
-
-
Kiss-Toth, E.1
Bagstaff, S.2
Sung, H.3
Jozsa, V.4
Dempsey, C.5
Caunt, J.6
Oxley, K.7
Wyllie, D.8
Polgar, T.9
Harte, M.10
O'Neill, L.11
Qwarnstrom, E.12
Dower, S.13
-
128
-
-
70349983266
-
A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia
-
Hegele, R.; Ban, M.; Hsueh, N.; Kennedy, B.; Cao, H.; Zou, G.; Anand, S.; Yusuf, S.; Huff, M.; Wang, J. A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by
-
(2009)
Hum. Mol. Genet
, vol.18
, pp. 4189-4194
-
-
Hegele, R.1
Ban, M.2
Hsueh, N.3
Kennedy, B.4
Cao, H.5
Zou, G.6
Anand, S.7
Yusuf, S.8
Huff, M.9
Wang, J.A.10
-
129
-
-
70349264255
-
FADS gene cluster polymorphisms: Important modulators of fatty acid levels and their impact on atopic diseases
-
Lattka, E.; Illig, T.; Heinrich, J.; Koletzko, B. FADS gene cluster polymorphisms: important modulators of fatty acid levels and their impact on atopic diseases. J. Nutrigenet. Nutrigenom., 2009, 2, 119-28.
-
(2009)
J. Nutrigenet. Nutrigenom
, vol.2
, pp. 119-128
-
-
Lattka, E.1
Illig, T.2
Heinrich, J.3
Koletzko, B.4
-
130
-
-
53849097341
-
FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease
-
Martinelli, N.; Girelli, D.; Malerba, G.; Guarini, P.; Illig, T.; Trabetti, E.; Sandri, M.; Friso, S.; Pizzolo, F.; Schaeffer, L.; Heinrich, J.; Pignatti, P.; Corrocher, R.; Olivieri, O. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am. J. Clin. Nutr., 2008, 88, 941-9.
-
(2008)
Am. J. Clin. Nutr
, vol.88
, pp. 941-949
-
-
Martinelli, N.1
Girelli, D.2
Malerba, G.3
Guarini, P.4
Illig, T.5
Trabetti, E.6
Sandri, M.7
Friso, S.8
Pizzolo, F.9
Schaeffer, L.10
Heinrich, J.11
Pignatti, P.12
Corrocher, R.13
Olivieri, O.14
-
131
-
-
0037395724
-
Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids
-
Kark, J.; Kaufmann, N.; Binka, F.; Goldberger, N.; Berry, E. Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am. J. Clin. Nutr., 2003, 77, 796-802.
-
(2003)
Am. J. Clin. Nutr
, vol.77
, pp. 796-802
-
-
Kark, J.1
Kaufmann, N.2
Binka, F.3
Goldberger, N.4
Berry, E.5
-
132
-
-
77950599045
-
The fatty acid desaturase 3 gene encodes for different FADS3 protein isoforms in mammalian tissues
-
Pédrono, F.; Blanchard, H.; Kloareg, M.; D'andréa, S.; Daval, S.; Rioux, V.; Legrand, P. The fatty acid desaturase 3 gene encodes for different FADS3 protein isoforms in mammalian tissues. J. Lipid Res., 2010, 51, 472-9.
-
(2010)
J. Lipid Res
, vol.51
, pp. 472-479
-
-
Pédrono, F.1
Blanchard, H.2
Kloareg, M.3
D'andréa, S.4
Daval, S.5
Rioux, V.6
Legrand, P.7
-
133
-
-
67651154428
-
Plasma phospholipid transfer protein (PLTP): Review of an emerging cardiometabolic risk factor
-
Tzotzas, T.; Desrumaux, C.; Lagrost, L. Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor. Obes. Rev., 2009, 10, 403-11.
-
(2009)
Obes. Rev
, vol.10
, pp. 403-411
-
-
Tzotzas, T.1
Desrumaux, C.2
Lagrost, L.3
-
134
-
-
67349151089
-
Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice
-
Samyn, H.; Moerland, M.; van Gent, T.; van Haperen, R.; Grosveld, F.; van Tol, A.; de Crom, R. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice. Atherosclerosis, 2009, 204, 429-34.
-
(2009)
Atherosclerosis
, vol.204
, pp. 429-434
-
-
Samyn, H.1
Moerland, M.2
van Gent, T.3
van Haperen, R.4
Grosveld, F.5
van Tol, A.6
de Crom, R.7
-
135
-
-
77951034342
-
Genetic and non-genetic sources of variation in phospholipid transfer protein (PLTP) activity
-
Jarvik, G.; Rajagopalan, R.; Rosenthal, E.; Wolfbauer, G.; McKinstry, L.; Vaze, A.; Brunzell, J.; Motulsky, A.; Nickerson, D.; Heagerty, P.; Wijsman, E.; Albers, J. Genetic and non-genetic sources of variation in phospholipid transfer protein (PLTP) activity. J. Lipid Res., 2010, 51, 983-990.
-
(2010)
J. Lipid Res
, vol.51
, pp. 983-990
-
-
Jarvik, G.1
Rajagopalan, R.2
Rosenthal, E.3
Wolfbauer, G.4
McKinstry, L.5
Vaze, A.6
Brunzell, J.7
Motulsky, A.8
Nickerson, D.9
Heagerty, P.10
Wijsman, E.11
Albers, J.12
-
136
-
-
66349110548
-
The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis
-
Masson, D.; Jiang, X.; Lagrost, L.; Tall, A. The role of plasma lipid transfer proteins in lipoprotein metabolism and atherogenesis. J. Lipid Res., 2009, 50 Suppl, S201-S206.
-
(2009)
J. Lipid Res
, Issue.50 SUPPL.
-
-
Masson, D.1
Jiang, X.2
Lagrost, L.3
Tall, A.4
-
137
-
-
67650270436
-
Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein
-
Dallinga-Thie, G.; van Tol, A.; Dullaart, R. Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein. Biochim. Biophys. Acta, 2009, 1791, 714-8.
-
(2009)
Biochim. Biophys. Acta
, vol.1791
, pp. 714-718
-
-
Dallinga-Thie, G.1
van Tol, A.2
Dullaart, R.3
-
138
-
-
35048834202
-
Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease
-
Attia, N.; Nakbi, A.; Smaoui, M.; Chaaba, R.; Moulin, P.; Hammami, S.; Hamda, K.; Chanussot, F.; Hammami, M. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease. Tohoku J. Exp. Med., 2007, 213, 129-37.
-
(2007)
Tohoku J. Exp. Med
, vol.213
, pp. 129-137
-
-
Attia, N.1
Nakbi, A.2
Smaoui, M.3
Chaaba, R.4
Moulin, P.5
Hammami, S.6
Hamda, K.7
Chanussot, F.8
Hammami, M.9
-
139
-
-
27944462756
-
Haplotypes in the phospholipid transfer protein gene are associated with obesity-related phenotypes: The Québec Family Study
-
Bossé, Y.; Bouchard, L.; Després, J.; Bouchard, C.; Pérusse, L.; Vohl, M. Haplotypes in the phospholipid transfer protein gene are associated with obesity-related phenotypes: the Québec Family Study. Int. J. Obes. (Lond), 2005, 29, 1338-45.
-
(2005)
Int. J. Obes. (Lond)
, vol.29
, pp. 1338-1345
-
-
Bossé, Y.1
Bouchard, L.2
Després, J.3
Bouchard, C.4
Pérusse, L.5
Vohl, M.6
-
140
-
-
6344278178
-
Effects of weight loss on PLTP activity and HDL particle size
-
Kaser, S.; Laimer, M.; Sandhofer, A.; Salzmann, K.; Ebenbichler, C.; Patsch, J. Effects of weight loss on PLTP activity and HDL particle size. Int. J. Obes. Relat. Metab. Disord., 2004, 28, 1280-2.
-
(2004)
Int. J. Obes. Relat. Metab. Disord
, vol.28
, pp. 1280-1282
-
-
Kaser, S.1
Laimer, M.2
Sandhofer, A.3
Salzmann, K.4
Ebenbichler, C.5
Patsch, J.6
-
141
-
-
0141919768
-
High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease
-
Schlitt, A.; Bickel, C.; Thumma, P.; Blankenberg, S.; Rupprecht, H.; Meyer, J.; Jiang, X. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 2003, 23, 1857-62.
-
(2003)
Arterioscler. Thromb. Vasc. Biol
, vol.23
, pp. 1857-1862
-
-
Schlitt, A.1
Bickel, C.2
Thumma, P.3
Blankenberg, S.4
Rupprecht, H.5
Meyer, J.6
Jiang, X.7
|